# Ranolazine (Ranolazine)

Source: https://ourhealthnetwork.com/drugs/ranolazine
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Ranolazine?

Ranolazine is an anti-anginal. It is prescribed to treat angina pectoris. Across the United States, 24,000 doctors prescribe Ranolazine to approximately 149,000 Medicare patients.

## Brand names

Ranolazine

## Indications

Ranolazine is primarily prescribed for the treatment of angina pectoris.

## Conditions treated

- [Angina Pectoris](https://ourhealthnetwork.com/conditions/angina-pectoris)

## Mechanism of action

The mechanism of action of ranolazine's antianginal effects has not been determined. Ranolazine has anti-ischemic and antianginal effects that do not depend upon reductions in heart rate or blood pressure.

## Drug classification

- Established Pharmacologic Class: Anti-anginal [EPC]
- Mechanism of Action class: Cytochrome P450 3A Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

and nausea, constipation, dizziness, headache, nausea, were dizziness

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)